Insulin is a hormone that regulates blood sugar levels in the body. People with diabetes need insulin to survive, and the cost of insulin has been a major concern for Canadians and Americans alike. In this article, we will compare the price of insulin in Canada and the United States.
Insulin Prices in Canada
Canada has a publicly funded healthcare system, which means that the cost of insulin is heavily subsidized by the government. This makes insulin more affordable for Canadians, and many people with diabetes are able to access the medication they need without financial hardship.
However, not all Canadians have equal access to insulin. In some provinces, insulin is only covered for certain populations, such as children and seniors. People with diabetes who do not fall into these categories may have to pay out of pocket for their insulin.
Insulin Prices in the United States
The United States does not have a publicly funded healthcare system, and the cost of insulin is not regulated by the government. This has led to a situation where the price of insulin is much higher in the US than in Canada.
According to a 2020 report by the House of Representatives' Committee on Oversight and Reform, the average price of insulin in the US has increased by over 500% in the past two decades. Many Americans with diabetes struggle to afford the medication they need, and some have even resorted to rationing their insulin or purchasing it from other countries.
Why is Insulin So Expensive in the US?
There are several reasons why insulin is so expensive in the US. One major factor is the lack of government regulation. Pharmaceutical companies are free to set their own prices for insulin, and there is little competition to drive prices down.
Another factor is the complicated supply chain for insulin. Insulin is manufactured by a few large pharmaceutical companies, and it must be transported and stored at specific temperatures to maintain its effectiveness. This adds to the cost of the medication.
Efforts to Lower Insulin Prices
There have been several efforts to lower the price of insulin in both Canada and the US. In Canada, the federal government has announced plans to create a national pharmacare program that would cover the cost of prescription drugs, including insulin, for all Canadians.
In the US, some states have passed laws to cap the price of insulin or require pharmaceutical companies to justify price increases. There have also been calls for the federal government to take action to regulate the cost of insulin.
Conclusion
The cost of insulin is a major concern for people with diabetes in both Canada and the United States. While insulin is more affordable in Canada due to the country's publicly funded healthcare system, not all Canadians have equal access to the medication. In the US, the lack of government regulation and the complicated supply chain for insulin have led to high prices that many Americans cannot afford. Efforts are underway in both countries to lower the cost of insulin and make it more accessible to those who need it.